*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
The Georgia Center for Diabetes Translation Research is having a center kickoff event on February 1, 2017 at Emory’s Rollins School of Public Health. Time will be from 2:30 pm until 6:00 pm (public talks followed by a reception).
Reminder: Applications for the pilot project funding RFA are due Feb 6, 2017. Learn more
2:30 pm - 4:00 pm:
Brian Elbel, PhD, MPH Associate Professor of Population Health and Health Policy, NYU School of Medicine "The role of Policy and the Environment on Obesity"
Elizabeth Mynatt, PhD, MS Professor and Executive Director of Institute for People and Technology, Georgia Institute of Technology "Opportunities for Diabetes Translation Research Collaboration at Georgia Tech"
Tabia Akintobi, PhD, MPH Associate Professor and Director of the Prevention Research Center, Morehouse School of Medicine "Opportunities for Diabetes Translation Research Collaboration at Morehouse School of Medicine"
4:00 pm - 6:00 pm:
Reception and Networking
Center Overview
Contact Bridgett Figueroa, bfiguer@emory.edu, for parking instructions.
ABOUT THE GEORGIA CENTER FOR DIABETES TRANSLATION RESEARCH (GCDTR)
The GCDTR is a collaboration of Emory University, Morehouse School of Medicine, and Georgia Institute of Technology that is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (P30DK111024) and inter‐institutional partners. The mission of the center is to facilitate and grow T2 diabetes translation research within the state of Georgia. T2 translation is defined as research focused on translating interventions/approaches that have clearly demonstrated efficacy into real world health care settings, communities, and populations at risk with an emphasis on reach, sustainability, and potential for widespread implementation. GCDTR facilitates research in three core areas: The Disparities Core addresses the roles of demographic, life‐span, race/ethnicity, immigration, and diabetes co‐morbidities on diabetes rates, treatment, and outcomes. The Design and Evaluation Core focuses on models of delivering effective preventive and health care services, including innovative use of technologies, workforce development, and/or metrics and evaluation. The Engagement and Behavior Change Core focuses on enhancing adoption and maintenance of prevention and care interventions for diabetes among those in need and incorporates expertise and resources from the fields of behavioral sciences, screening, and community‐based participatory research.
